Hyponatremia: Difference between revisions
(References consolidation) |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Defined as sodium concentration <135meq/L<ref>Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Seminars in Nephrology 2009 29 227–238</ref> | *Defined as sodium concentration <135meq/L<ref>Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Seminars in Nephrology 2009 29 227–238</ref> | ||
*Patients often not symptomatic until <120meq/L, although this level varies by patients and may be higher if the change occurred abruptly<ref>Spasovski | *Patients often not symptomatic until <120meq/L, although this level varies by patients and may be higher if the change occurred abruptly<ref name="Spasovski">Spasovski et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 0: 1–39. [http://ndt.oxfordjournals.org/content/early/2014/02/21/ndt.gfu040.full.pdf fulltext]</ref> | ||
*Too fast of sodium correction (>10 mmol/L/day), especially if chronic, can cause [[osmotic demyelination syndrome]] (central pontine myelinolysis)<ref name="NEJM">Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000 May 25;342(21):1581-9.</ref> | *Too fast of sodium correction (>10 mmol/L/day), especially if chronic, can cause [[osmotic demyelination syndrome]] (central pontine myelinolysis)<ref name="NEJM">Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000 May 25;342(21):1581-9.</ref> | ||
==Clinical Features== | ==Clinical Features== | ||
===Hyponatremia Symptoms by Severity<ref | ===Hyponatremia Symptoms by Severity<ref name="Spasovski" />=== | ||
{| {{table}} | {| {{table}} | ||
| align="center" style="background:#f0f0f0;"|'''Severity''' | | align="center" style="background:#f0f0f0;"|'''Severity''' | ||
| Line 73: | Line 73: | ||
===Pseudohyponatremia=== | ===Pseudohyponatremia=== | ||
*Hyperglycemia | *Hyperglycemia | ||
**Na+ decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL<ref>Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399–403</ref> | **Na+ decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL<ref name="Hillier">Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399–403</ref> | ||
*Displaced sodium in lab specimen | *Displaced sodium in lab specimen | ||
**Hyperlipidemia | **Hyperlipidemia | ||
| Line 96: | Line 96: | ||
===Diagnosis=== | ===Diagnosis=== | ||
[[File:Hyponatremia correction.png|thumb|True serum sodium (corrected) based on serum glucose<ref | [[File:Hyponatremia correction.png|thumb|True serum sodium (corrected) based on serum glucose<ref name="Spasovski" />]] | ||
[[File:Hyponatremia.png|thumb|Algorithm for hyponatremia diagnosis]] | [[File:Hyponatremia.png|thumb|Algorithm for hyponatremia diagnosis]] | ||
#Correct for glucose (see table) | #Correct for glucose (see table) | ||
| Line 105: | Line 105: | ||
''Defined as osmolarity > 295mmol/L with the following causes:'' | ''Defined as osmolarity > 295mmol/L with the following causes:'' | ||
#[[Hyperglycemia]] | #[[Hyperglycemia]] | ||
#*Sodium decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL<ref | #*Sodium decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL<ref name="Hillier" /> | ||
#[[Mannitol]] excess | #[[Mannitol]] excess | ||
| Line 120: | Line 120: | ||
===Severe Symptoms (See Clinical Features)=== | ===Severe Symptoms (See Clinical Features)=== | ||
'''Adults:<ref | '''Adults:<ref name="Spasovski" />''' | ||
#3% hypertonic saline 150 mL bolus over 20 min | #3% hypertonic saline 150 mL bolus over 20 min | ||
#Check serum sodium concentration after 20 min | #Check serum sodium concentration after 20 min | ||
| Line 131: | Line 131: | ||
===Moderately Severe Symptoms=== | ===Moderately Severe Symptoms=== | ||
'''Adults:<ref | '''Adults:<ref name="Spasovski" />''' | ||
#3% hypertonic saline 150 mL bolus over 20 min | #3% hypertonic saline 150 mL bolus over 20 min | ||
#Start prompt diagnostic assessment and provide cause-specific treatment | #Start prompt diagnostic assessment and provide cause-specific treatment | ||
| Line 140: | Line 140: | ||
===NOT Severe/Moderately-Severe (Including Asymptomatic)=== | ===NOT Severe/Moderately-Severe (Including Asymptomatic)=== | ||
'''Adults:<ref | '''Adults:<ref name="Spasovski" />''' | ||
#Start prompt diagnostic assessment and provide cause-specific treatment | #Start prompt diagnostic assessment and provide cause-specific treatment | ||
#Check serum sodium concentration after 4 hours | #Check serum sodium concentration after 4 hours | ||
| Line 157: | Line 157: | ||
===Hypotonic hyponatremia=== | ===Hypotonic hyponatremia=== | ||
#Hypovolemic | #Hypovolemic | ||
#*Give normal saline, but be cautious of raising the serum sodium more than 10 mmol/L/day and causing [[osmotic demyelination syndrome]] (central pontine myelinolysis)''<ref>Nagler EV1, Vanmassenhove J, van der Veer SN et al. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276109/ BMC Med. 2014 Dec 11;12:1]</ref>'' | #*Give normal saline, but be cautious of raising the serum sodium more than 10 mmol/L/day and causing [[osmotic demyelination syndrome]] (central pontine myelinolysis)''<ref name="Nagler">Nagler EV1, Vanmassenhove J, van der Veer SN et al. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276109/ BMC Med. 2014 Dec 11;12:1]</ref>'' | ||
#Euvolemic<ref name="treatment"></ref> | #Euvolemic<ref name="treatment"></ref> | ||
#*Water restrict | #*Water restrict | ||
| Line 167: | Line 167: | ||
==Calculating Sodium Replacement Therapy== | ==Calculating Sodium Replacement Therapy== | ||
''Max correction 10mEq/L in first 24hr (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached (lowers risk of [[osmotic demyelination syndrome]]) <ref | ''Max correction 10mEq/L in first 24hr (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached (lowers risk of [[osmotic demyelination syndrome]]) <ref name="Nagler" />'' | ||
===Step 1=== | ===Step 1=== | ||
Calculate total body water<ref>The hyponatremia formulas do not work so well (Clin J Am Soc Nephrol 2007;2:1110 and Nephrol Dial Transplant 2006;21:1564)</ref> | Calculate total body water<ref>The hyponatremia formulas do not work so well (Clin J Am Soc Nephrol 2007;2:1110 and Nephrol Dial Transplant 2006;21:1564)</ref> | ||
Revision as of 09:31, 4 November 2017
Background
- Defined as sodium concentration <135meq/L[1]
- Patients often not symptomatic until <120meq/L, although this level varies by patients and may be higher if the change occurred abruptly[2]
- Too fast of sodium correction (>10 mmol/L/day), especially if chronic, can cause osmotic demyelination syndrome (central pontine myelinolysis)[3]
Clinical Features
Hyponatremia Symptoms by Severity[2]
| Severity | NOT severe | Moderately severe | Severe |
| Symptoms |
|
Symptoms from Rapid Correction of Sodium
- CHF
- Osmotic demyelination syndrome (central pontine myelinolysis)
Differential Diagnosis of Hypotonic Hyponatremia (by Volume Status)
Hypovolemic
Renal Causes
- Thiazide diuretic use
- Na-wasting nephroathy (RTA, CRF)
- Osmotic diuresis (glucose, urea)
- Aldosterone deficiency
Extra-renal Causes
- GI loss
- 3rd space loss
- Burns
- Pancreatitis
- Peritonitis
Hypervolemic
- Urinary Na >20
- Urinary Na <20
Euvolemic
- SIADH
- urine sodium is greater than 20-40 mEq/L
- Pain, stress, nausea
- Psychogenic polydipsia
- Hypothyroidism
- Drugs[4][5]
- NSAIDs, sulfonylureas, wellbutrin
- H20 intoxication
- Glucocorticoid deficiency
Pseudohyponatremia
- Hyperglycemia
- Na+ decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL[6]
- Displaced sodium in lab specimen
- Hyperlipidemia
- Hyperproteinemia
Evaluation
Work-Up
Prior to giving treatment
- Urine
- Urinalysis
- Urine electrolytes
- Urine urea
- urine uric acid
- urine osmolality
- urine creatinine
- Serum
- Chemistry
- Serum osmolality
- Uric acid
- TSH
- Cortisol
Diagnosis
- Correct for glucose (see table)
- Determine volume status
- Calculated osm (in true hyponatremia the osm is reduced)
Hypertonic Hyponatremia
Defined as osmolarity > 295mmol/L with the following causes:
- Hyperglycemia
- Sodium decreases by 2.4mEq/L for each 100mg/dL increase in glucose over 100mg/dL[6]
- Mannitol excess
Isotonic (pseudo) hyponatremia
Defined as osmolarity > 275-295mmol/L. Often referred to as pseudo hyponatremia because the elevated lipids or proteins interfere with the laboratory sodium reading. The following are common causes:
- Hyperlipidemia
- Hyperproteinemia
Hypotonic Hyponatremia
Defined as an osmolarity < 275 mmol/L and categorized as hypovolemic, hypervolemic or euvolemic
General Management
Must have sufficient confidence that the symptoms are caused by hyponatraemia
Severe Symptoms (See Clinical Features)
Adults:[2]
- 3% hypertonic saline 150 mL bolus over 20 min
- Check serum sodium concentration after 20 min
- Repeat infusion of 150 ml 3% hypertonic saline for the next 20 min
- Repeat twice or until a target of 5 mmol/l increase in serum sodium concentration is achieved
- Each 100 mL will raise sodium by ~2 mmol/l
- In general, 200-400 mL of 3% hypertonic saline is reasonable dose in most adult patients with severe symptomatic hyponatremia, which may be given IV over 1-2 hr until resolution of seizures.
Pediatrics:[7]
- 2 mL/kg of 3% over 10-60 minutes can be infused with a repeat of up to 3 times.
Moderately Severe Symptoms
Adults:[2]
- 3% hypertonic saline 150 mL bolus over 20 min
- Start prompt diagnostic assessment and provide cause-specific treatment
- Check serum sodium concentration after 1, 6 and 12 hours
- Aim for a 5 mmol/l per 24-h increase in serum sodium concentration
- Limit increase to 10 mmol/l in the first 24 h (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached
- Manage the patient as in severely symptomatic hyponatraemia if the serum sodium concentration further decreases despite treating the underlying diagnosis (2D).
NOT Severe/Moderately-Severe (Including Asymptomatic)
Adults:[2]
- Start prompt diagnostic assessment and provide cause-specific treatment
- Check serum sodium concentration after 4 hours
- Aim for a 5 mmol/l per 24-h increase in serum sodium concentration
- Limit increase to 10 mmol/l in the first 24 h (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached
- Manage the patient as in moderately-severe symptomatic hyponatraemia if the serum sodium concentration decreases 10 mmol/l
Cause-Specific Treatment
Hypertonic hyponatremia
- Correct underlying disorder which is often hyperglycemia[8]
- Often volume depleted due to osmotic diuresis and normal saline provides adequate volume repletion
Isotonic (pseudo) hyponatremia
- No treatment needed [8]
Hypotonic hyponatremia
- Hypovolemic
- Give normal saline, but be cautious of raising the serum sodium more than 10 mmol/L/day and causing osmotic demyelination syndrome (central pontine myelinolysis)[9]
- Euvolemic[8]
- Water restrict
- Treat underlying cause
- Hypervolemic
- Water restriction
- Diuresis
- Treat underlying cause
Calculating Sodium Replacement Therapy
Max correction 10mEq/L in first 24hr (8 mmol/l during every 24 h thereafter), until a serum sodium concentration of 130 mmol/l is reached (lowers risk of osmotic demyelination syndrome) [9]
Step 1
Calculate total body water[10]
- TBW(kg) = Wt(kg) x 0.6 = [Wt(lb) x 0.45] x 0.6 = Wt(lb) x 0.27
Step 2
Calculate mEq deficit
- (Desired Na - Measured Na) ~ must be ≤ 10
Step 3
Calculate NS rate to be given over 24hr
- NS rate (cc/hr) = TBW x mEq deficit x 0.27
- If using 3% sodium chloride (to avoid volume overload) divide above rate by 3.33
| Fluid type | Sodium Concentration |
| 1/2 Normal Saline | 77 mEq/L |
| Normal Saline | 154 mEq/L |
| Lactated Ringers | 130 mEq/L |
| 3% Saline | 513 mEq/L |
Disposition
- Admit if symptomatic or if Na <125mEq/L
- Manage severely symptomatic patients in "an environment where close biochemical and clinical monitoring can be provided" (e.g. ICU)
See Also
External Links
References
- ↑ Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Seminars in Nephrology 2009 29 227–238
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Spasovski et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 0: 1–39. fulltext
- ↑ Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000 May 25;342(21):1581-9.
- ↑ Review of Drug-Induced Hyponatremia. Am J Kidney Dis 2008;52:144
- ↑ Kate M, Grover S. Bupropion-Induced Hyponatremia. General Hospital Psychiatry Volume 35, Issue 6, November–December 2013, 681-683.
- ↑ 6.0 6.1 Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399–403
- ↑ Moritz ML, Ayus JC. 100cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010 Mar; 25(1): 91-6.
- ↑ 8.0 8.1 8.2 Schrier RW, Bansal S. Diagnosis and management of hyponatremia in acute illness. Curr Opin Crit Care 2008;14:627-34
- ↑ 9.0 9.1 Nagler EV1, Vanmassenhove J, van der Veer SN et al. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med. 2014 Dec 11;12:1
- ↑ The hyponatremia formulas do not work so well (Clin J Am Soc Nephrol 2007;2:1110 and Nephrol Dial Transplant 2006;21:1564)
